<DOC>
	<DOCNO>NCT02937519</DOCNO>
	<brief_summary>1 . Observe compare chrono-chemotherapy IMRT conventional chemotherapy intensity modulate radiotherapy term efficacy treatment locally advanced nasopharyngeal carcinoma . 2 . Evaluation chrono-chemotherapy IMRT conventional chemotherapy intensity modulate radiotherapy locally advanced nasopharyngeal carcinoma safety tolerability . 3）observing adverse reaction effect two group , expect chrono-chemotherapy group achieve low toxicity , improve curative effect , treatment nasopharyngeal carcinoma provide reasonable way .</brief_summary>
	<brief_title>Chronomodulated Chemotherapy Followed Concurrent Chemo-radiotherapy With IMRT Treatment Advanced Nasopharyngeal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>initial treatment advance nasopharyngeal carcinoma ⅢⅣ patient pathologically confirm ( accord 2010 UICC staging , T34 , N03 ) , without evidence distant metastasis ( M0 ) . Have measurable tumor lesion . KPS≥70 point . age 1870 year old , male female . major organ dysfunction ; normal bone marrow function ( WBC ≥4.0 × 109 / L , platelets ≥100 × 109 / L , hemoglobin ≥90g / L ) , normal liver function ( total bilirubin , alanine aminotransferase , aspartate aminotransferase ≤1.5 time upper limit normal ) , normal renal function ( creatinine ≤ 1.5 time upper limit normal ) . understand study sign informed consent . distant metastasis . receive prior chemotherapy . patient physical mental illness , researcher believe patient completely fully understood study possible complication . pregnancy ( via urine serum βHCG test confirm ) lactation . serious complication , uncontrolled hypertension , heart failure , diabetes .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Chronomodulated Chemotherapy</keyword>
	<keyword>Intensity Modulated Radiation Therapy</keyword>
	<keyword>Advanced Nasopharyngeal Cancer</keyword>
</DOC>